| Dr Rainer S Vogel, MD | |
|
10561 Jeffreys St, Suite 211, Henderson, NV 89052-4266 | |
| (702) 990-4530 | |
| (702) 990-4527 |
| Full Name | Dr Rainer S Vogel |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 27 Years |
| Location | 10561 Jeffreys St, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396727756 | NPI | - | NPPES |
| 100506850 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 11534 (Nevada) | Primary |
| Entity Name | Rainer S Vogel Md Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427191634 PECOS PAC ID: 1456386416 Enrollment ID: O20050928001516 |
News Archive
The majority of top-rated fertility apps collect and even share intimate data without the users' knowledge or permission, a collaborative study by Newcastle University and Umea University has found.
Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
Meda and Valeant have entered into a collaboration agreement. Meda has out-licensed exclusive rights for Elidel and Xerese to Valeant for the U.S., Canada and Mexico. The parties will collaborate on life cycle opportunities for both products.
› Verified 4 days ago
| Entity Name | Comprehensive And Interventional Pain Management Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295013555 PECOS PAC ID: 5193996668 Enrollment ID: O20110914000584 |
News Archive
The majority of top-rated fertility apps collect and even share intimate data without the users' knowledge or permission, a collaborative study by Newcastle University and Umea University has found.
Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
Meda and Valeant have entered into a collaboration agreement. Meda has out-licensed exclusive rights for Elidel and Xerese to Valeant for the U.S., Canada and Mexico. The parties will collaborate on life cycle opportunities for both products.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rainer S Vogel, MD 10561 Jeffreys St, Suite 211, Henderson, NV 89052-4266 Ph: (702) 990-4530 | Dr Rainer S Vogel, MD 10561 Jeffreys St, Suite 211, Henderson, NV 89052-4266 Ph: (702) 990-4530 |
News Archive
The majority of top-rated fertility apps collect and even share intimate data without the users' knowledge or permission, a collaborative study by Newcastle University and Umea University has found.
Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
Meda and Valeant have entered into a collaboration agreement. Meda has out-licensed exclusive rights for Elidel and Xerese to Valeant for the U.S., Canada and Mexico. The parties will collaborate on life cycle opportunities for both products.
› Verified 4 days ago
Raman S Grewal, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 129 W Lake Mead Pkwy, B-18, Henderson, NV 89015 Phone: 702-564-4440 Fax: 702-558-1522 | |
Michael A Fortunato, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: Valley Anesthesiology Consultants, 10120 S. Eastern Ave., Suite 130, Henderson, NV 89052 Phone: 702-487-6510 Fax: 702-405-7960 | |
Samuel D Rosenthal, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10120 S Eastern Ave #130, Henderson, NV 89052 Phone: 702-487-6880 Fax: 702-473-5455 | |
Gabriel Garcia, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 129 W Lake Mead Pkwy, #b-18, Henderson, NV 89015 Phone: 702-564-4440 Fax: 702-558-1522 | |
Dr. Andrew Malek, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10120 S Eastern Ave, Henderson, NV 89052 Phone: 702-487-6880 | |
Daniel E Batlan, MD, MBA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1661 W Horizon Ridge Pkwy, Suite #270, Henderson, NV 89012 Phone: 702-838-8004 Fax: 702-838-5085 | |
Laura Santos Pavia, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10120 S Eastern Ave #130, Henderson, NV 89052 Phone: 702-487-6880 Fax: 702-473-5455 |